40 reports

  • APPLICATIONS OF BANDAGE CONTACT LENSES

MANY SUCH LENSES ARE BEING EVALUATED FOR THE CONTROLLED DELIVERY OF THE OPHTHALMIC DRUGS AND IMPROVING OCULAR BIOAVAILABILITY.

  • Eye Disease
  • APAC
  • North America
  • United States
  • World

Ocular' s hydrogel provides containment, localization and protection from inflammatory response, and a material for sustained delivery of drugs to the eye.

  • Eye Disease
  • Ophthalmology
  • United States
  • Company
  • Ocular Therapeutix, Inc.
  • ASSET PURCHASE

Ohr has a sustained-release micro-fabricated micro-particle ocular drug delivery platform technology that utilizes hydrogel template approach to prepare microparticles or other configurations.

  • Eye Disease
  • United States
  • Company
  • Company Operations
  • Ohr Pharmaceutical Inc.
  • EQUITY OFFERING
  • LICENSING AGREEMENTS

Graybug Vision' s proprietary ocular drug delivery technologies enable the delivery of the compounds to the various compartments of the eye.

  • Eye Disease
  • Pharmaceutical
  • United States
  • Company
  • Graybug Vision, Inc.
  • DEXAMETHASONE PHOSPHATE - DRUG PROFILE

EGP-## will be administered using the EyeGate II Ocular Drug Delivery System.

  • Eye Disease
  • Ophthalmology
  • United States
  • Product Initiative
  • EyeGate Pharmaceuticals, Inc.
  • DRUGS FOR ALLERGIC CONJUNCTIVITIS - DRUG PROFILE

The drug candidates are developed based on sustained release microfabrication ocular drug delivery technology.

  • Eye Disease
  • Ophthalmic Solution
  • United States
  • Product Initiative
  • Aldeyra Therapeutics, Inc.

Ocular' s hydrogel provides containment, localization and protection from inflammatory response, and a material for sustained delivery of drugs to the eye.

  • Eye Disease
  • Ophthalmic Solution
  • Pharmaceutical
  • United States
  • Product Initiative

The company provides services such as drug formulations, drug delivery, drug discovery, clinical trials, ocular therapeutics, eye treatment services.

  • Eye Disease
  • Medical Biotechnology
  • United States
  • Product Initiative
  • Galapagos NV
  • Durasert Technology

The company provides drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness.

  • Eye Disease
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative

Graybug Vision' s proprietary ocular drug delivery technologies enable the delivery of the compounds to the various compartments of the eye.

  • Eye Disease
  • Ophthalmology
  • Pharmaceutical
  • United States
  • Aerie Pharmaceuticals, Inc.
  • GENE SIGNAL INTERNATIONAL SA
  • RETINAL VEIN OCCLUSION - PIPELINE BY GRAYBUG VISION INC, H1 2018

EGP-## will be administered using the EyeGate II Ocular Drug Delivery System.

  • Eye Disease
  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • United States
  • SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS: PIPELINE
  • 6.13.4. SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS PORTFOLIO

OCULAR DRUG DELIVERY SYSTEMS ##. ##. ##.

  • Eye Disease
  • North America
  • United States
  • Allergan plc
  • Neurotech Pharmaceuticals, Inc.
  • GLAUKOS CORP
  • DRUGS FOR STEROID INDUCED GLAUCOMA - DRUG PROFILE

Graybug Vision' s proprietary ocular drug delivery technologies enable the delivery of the compounds to the various compartments of the eye.

  • Eye Disease
  • Ophthalmology
  • United States
  • Company
  • Product Initiative

Glaucoma and Retinopathies 2010 focused on the latest advances in ocular neuroprotection, drug delivery and antivascular therapies.

  • Eye Disease
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.

Contact lenses have been studied as a means of ocular drug delivery for nearly ## years, yet many such lenses are ineffective because they dispense the drug too quickly.

  • Clinical Trial
  • Eye Disease
  • Eyewear
  • Ophthalmology
  • Valeant Pharmaceuticals International, Inc.

MDT poster session, data from ongoing research collaboration between RXi Pharmaceuticals and Jade Therapeutics, on work in the area of corneal drug delivery to reduce scar formation, will be presented.

  • Eye Disease
  • United States
  • Litigation And Patent
  • Product Initiative
  • RXi Pharmaceuticals Corporation

Glaucoma and Retinopathies 2010 focused on the latest advances in ocular neuroprotection, drug delivery and antivascular therapies.

  • Eye Disease
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.
  • Durasert Technology

The company provides drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness.

  • Eye Disease
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative
  • Novaliq Raises US$18 Million In Venture Financing

We are delighted to further invest in Novaliq, with its pioneering ocular drug delivery technology and strong management team. "

  • Eye Disease
  • Pharmaceutical
  • Germany
  • Company
  • Novaliq GmbH
  • DIABETIC MACULAR EDEMA - PIPELINE BY FORMYCON AG, H1 2019
  • OHR PHARMACEUTICAL INC

EGP-## will be administered using the EyeGate II Ocular Drug Delivery System.

  • Eye Disease
  • Medical Biotechnology
  • United States
  • Company
  • Product Initiative
  • FORMYCON AG
  • DIABETIC MACULAR EDEMA - PIPELINE BY GRAYBUG VISION INC, H2 2019

Graybug Vision' s proprietary ocular drug delivery technologies enable the delivery of the compounds to the various compartments of the eye.

  • Eye Disease
  • Medical Biotechnology
  • United States
  • Product Initiative
  • Clearside Biomedical, Inc.
  • 5.2.24 GRAYBUG VISION INC
  • GLAUCOMA - PIPELINE BY GRAYBUG VISION INC, H2 2018

GRAYBUG VISION' S PROPRIETARY OCULAR DRUG DELIVERY TECHNOLOGIES ENABLE THE DELIVERY OF THE COMPOUNDS TO THE VARIOUS COMPARTMENTS OF THE EYE.

  • Eye Disease
  • Ophthalmology
  • Pharmaceutical
  • Type 2 Diabetes
  • Product Initiative
  • OCULAR THERAPEUTIX INC
  • GENE SIGNAL INTERNATIONAL SA

GRAYBUG VISION' S PROPRIETARY OCULAR DRUG DELIVERY TECHNOLOGIES ENABLE THE DELIVERY OF THE COMPOUNDS TO THE VARIOUS COMPARTMENTS OF THE EYE.

  • Eye Disease
  • Ophthalmology
  • Therapy
  • United States
  • Product Initiative

THE DRUG CANDIDATE IS DEVELOPED BASED ON EYESOL DRUG DELIVERY TECHNOLOGY WHICH COMPRISES OF SEMIFLUORINATED ALKANES (SFAS) AS DRUG DELIVERY MEDIUM.

  • Eye Disease
  • Ophthalmology
  • Pharmaceutical
  • Therapy
  • Product Initiative
  • GENSIGHT BIOLOGICS SA
  • AGE RELATED MACULAR DEGENERATION - PIPELINE BY GRAYBUG VISION INC, H1 2018

Graybug Vision" s proprietary ocular drug delivery technologies enable the delivery of the compounds to the various compartments of the eye.

  • Eye Disease
  • Monoclonal Antibody
  • Ophthalmology
  • Pharmaceutical
  • Allergan plc
  • BACK OF THE EYE DISORDERS: DRUG DELIVERY TECHNOLOGIES / SYSTEMS
  • 7. MARKET SIZE AND OPPORTUNITY ANALYSIS

OCULAR DRUG DELIVERY TECHNOLOGY (GRAYBUG VISION) Parameters Name of the Technology Developer (HQ) Type of Technology Mechanism of Action Details Ocular Drug Delivery Technology Graybug Vision (US) Drug Delivery Technology The te

  • Eye Disease
  • United States
  • Alcon, Inc.
  • Allergan plc
  • Novartis AG

EGP-## will be administered using the EyeGate II Ocular Drug Delivery System.

  • Autoimmune Disease
  • Eye Disease
  • United States
  • Product Initiative
  • Galapagos NV

Contact lenses have been studied as a means of ocular drug delivery for nearly ## years, yet many such lenses are ineffective because they dispense the drug too quickly.

  • Eye Disease
  • Medical Device
  • United States
  • Company
  • Valeant Pharmaceuticals International, Inc.

Ocular Immunology and Inflammatory; ##: ##-##.

  • Eye Disease
  • AbbVie Inc.
  • Clearside Biomedical, Inc.
  • pSivida Corp.
  • Santen Pharmaceutical Co., Ltd.

ACIONT OFFERS SERVICES SUCH AS DRUG FORMULATIONS, DRUG DELIVERY, DRUG DISCOVERY, CLINICAL TRIALS, OCULAR THERAPEUTICS, AND EYE TREATMENT SERVICES.

  • Eye Disease
  • Ophthalmology
  • Therapy
  • United States
  • Product Initiative